Voleon Capital Management’s Amedisys AMED Stock Holding History

Voleon Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,000	Closed	-$1.33M	–	11
2019 Q4	$1.33M	Buy	+8,000	New	+$1.19M	0.08%	133

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Voleon Capital Management's AMED Position: Q1 2020 in Review

Voleon Capital Management sold out of Amedisys (AMED) in Q1 2020, closing a stake of 8,000 shares — an estimated $1.33M sold.

Voleon Capital Management first reported a position in AMED in Q4 2019 and held it in 1 quarter. The position peaked at $1.33M in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

Voleon Capital Management reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
Voleon Capital Management sold 8,000 Amedisys shares in Q1 2020, an estimated $1.33M.
Voleon Capital Management first reported a position in Amedisys in Q4 2019 and held it in 1 quarter.
Voleon Capital Management's Amedisys position peaked at $1.33M in Q4 2019.
332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Voleon Capital Management's 13F filing for Q1 2020.